Abstract |
Atherosclerotic plaque is the primary cause of cardiovascular disorders and remains a therapeutic hurdle for the early intervention of atherosclerosis. Traditional clinical strategies are often limited by surgery-related complications or unsatisfactory effects of long-term drug administration. Inspired by the plaque-binding ability of platelets, a biomimic photodynamic therapeutic system is designed to mitigate the progression of atherosclerotic plaques. This system is composed of photosensitizer-loaded upconversion nanoparticle cores entrapped in the platelet membrane. The platelet membrane coating facilitates specific targeting of the therapeutic system to macrophage-derived foam cells, the hallmark, and main component of early stage atherosclerotic plaques, which is firmly confirmed by in vivo fluorescent and single-photon emission computed tomography/computed tomography (SPECT/CT) radionuclide imaging. Importantly, in vivo phototherapy guided by SPECT/CT imaging alleviates plaque progression. Further immunofluorescence analysis reveals foam cell apoptosis and ameliorated inflammation. This biomimic system, which combines plaque-binding with radionuclide imaging guidance, is a novel, noninvasive, and potent strategy to mitigate the progression of atherosclerotic plaque.
|
Authors | Yi Ma, Yuxuan Ma, Mengqiu Gao, Zhihao Han, Wen Jiang, Yueqing Gu, Yi Liu |
Journal | Advanced science (Weinheim, Baden-Wurttemberg, Germany)
(Adv Sci (Weinh))
Vol. 8
Issue 8
Pg. 2004128
(04 2021)
ISSN: 2198-3844 [Electronic] Germany |
PMID | 33898191
(Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
|
Copyright | © 2021 The Authors. Advanced Science published by Wiley‐VCH GmbH. |
Topics |
- Animals
- Blood Platelets
- Disease Models, Animal
- Disease Progression
- Mice
- Phototherapy
(methods)
- Plaque, Atherosclerotic
(diagnostic imaging, therapy)
- Single Photon Emission Computed Tomography Computed Tomography
(methods)
|